Professor Savoie is a recognized authority on regional development. He is regularly consulted by the federal government and several provinces. Dr. Savoie has authored several widely acclaimed books with Canada's leading university presses and edited a number of important books. He has published articles in both English and French in national and international journals. In 1983 he founded the Canadian Institute for Research on Regional Development and quickly gave it an international reputation as a leading centre of excellence in regional studies. Scholars from Canada, United States, France, Poland, Belgium and Australia have collaborated or held visiting status with the institute.

George A. Sawatzky is recognized as one of the most respected researchers in the field of condensed matter. His pioneering work on the electronic structure of strongly correlated systems, and his contribution to the understanding of physical properties of transition metal oxides and the interplay between the spin, charge and orbital degrees of freedom have made him a much sought-after speaker at international conferences.

Professor Michael Sayer, of Queen's University, with research interests in solid state physics, has been a leader in bringing to Canadian industry the results of his scholarship. His research group has produced new knowledge and understanding of ceramic materials and have brought to industrial development acoustic transducers, ferro-electric detectors, thermo-electric power generation materials, superconducting demonstration ceramics for high schools, and recently a sol gel process to make thin film transducers for optical fibers. Dr. Sayer has also created and managed many effective collaborations between industry and university and has encouraged this activity and attitude through his many students and colleagues.

Robert .0. Scagel has been productive in botanical research. His contributions to phycology have led to the following honours: Appointment as professor in botany and oceanography at the University of British Columbia; as summer session teacher in oceanography at the University of Washington; as representative of Canada and member of the Standing Committee on Oceanography in the Pacific Science Congress; and as one of the two chief researchers on algae in the present survey of the Indian Ocean from the Red Sea to the Cape of Good Hope, undertaken by the National Science Foundation of U.S.A.

Marlene Scardamalia’s theoretical, pedagogical and technological innovations have helped to create and shape a new field of inquiry: Knowledge Building. Knowledge Building engages students directly in the means by which knowledge in the world is advanced. Scardamalia’s award-winning research and development spanning a global network of hubs of innovation is making knowledge creation, previously reserved for a few, central to education for all students at all levels.

Marlene Scardamalia et ses innovations théoriques, pédagogiques et technologiques ont contribué à créer et à façonner un nouveau champ d’investigation : la construction du savoir. La construction du savoir engage directement les étudiants dans les moyens d’avancement des connaissances dans le monde. La recherche et le développement primés de Scardamalia, qui couvrent un réseau mondial de centres d’innovation, font de la création de connaissances, auparavant réservée à quelques-uns, un élément central de l’éducation pour les étudiants de tous les niveaux.

Dr. Schachter's major concern has been the biological synthesis, by enzymes (glycosyltransferases), of complex carbohydrates, important and unique components of all cell surfaces. He is a major figure in the field, through his research, his guidance of graduate students, and his lectures and written reviews. He was a pioneer with many unique contributions, including the first to localize these enzymes in the Golgi apparatus, thereby pointing to its important role in glycosylation, and the first to systematically isolate and characterize key glycosyltransferases (ten of them) involved in glycan branching and core synthesis, and to delineate the rules which control the synthesis of these highly complex structures. The biochemistry and molecular biology of these enzymes has since become a major field of study by his laboratory and others interested in the functions of complex carbohydrates and in the development of new therapeutic approaches to cancer metastasis, inflammation and other areas of medicine.

SCHAFER, Laurel - Department of Chemistry, The University of British Columbia Prof. Laurel Schafer has made seminal research contributions bridging the areas of organometallic and organic chemistry; she has developed a versatile ground-breaking new class of early transition metal complexes for use in selective carbon-nitrogen and carbon-carbon bond forming reactions of industrial relevance. These new catalytic systems synergistically minimise waste and maximise energy efficiency by utilising metals of low toxicity for sustainable approaches towards selective and specific chemical transformations.

John Scheffer has attained worldwide recognition for his pioneering research in the field of solid-state organic chemistry. Scheffer is the author of over 200 research publications and the recipient of a number of fellowships and awards, most recently the 2000 Alfred Bader Lecture Award of the Canadian Society for Chemistry.

Long Citation Stephen Scherer is one of Canada's leading geneticists making seminal contributions to the understanding of the human genome. He is internationally known for contributions to decoding the sequence of human chromosome 7, including the identification of 20 disease causing genes. His group also discovered the phenomena of large structural alterations as a common type of variation in the human genome contributing to both disease and evolution of chromosomes. He has published over 650 publications, won numerous awards including the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, and multiple Honorary degrees. Dr. Scherer is currently the Chief of Research at The Hospital for Sick Children (SickKids) in Toronto, Canada. Short Citation Stephen Scherer is an internationally known geneticists making seminal contributions to the understanding of the human genome. His group discovered the phenomena of large structural alterations as a common type of variation in the human genome contributing to both disease and evolution of chromosomes. Dr. Scherer has won numerous awards including the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, and multiple Honorary degrees. Dr. Scherer is currently the Chief of Research at The Hospital for Sick Children (SickKids) in Toronto, Canada.

Long Citation Ernesto Schiffrin is one of the great clinical scientists in Canada, and a world leader in the field of the mechanisms and management of arterial hypertension. Amongst many contributions, he demonstrated that anti-hypertensive drugs interfering with the renin-angiotensin-aldosterone system correct blood pressure and the structural remodeling of resistance arterioles, and he showed the role of endothelin in this vascular remodeling. Dr. Schiffrin brings together a profound knowledge of molecular and clinical medicine. His fundamental work has been recognized amongst many honours by his election as President of the American Heart Association Council for High Blood Pressure Research. Short Citation Ernesto Schiffrin is one of the great clinical scientists in Canada, and a world leader in the field of the mechanisms and management of arterial hypertension. Amongst many contributions, he demonstrated that anti-hypertensive drugs interfering with the renin-angiotensin-aldosterone system correct blood pressure and the structural remodeling of resistance arterioles. He also showed the role of endothelin in this vascular remodeling.

Dr. Aaron Schimmer is an international authority in cancer research focused on blood cancers known as leukemia. Through multiple pioneering discoveries, he has demonstrated how mitochondrial and metabolic pathways influence the development and progression of acute myeloid leukemia. As a clinician-scientist, he has translated these breakthroughs into the clinic by launching early phase clinical trials to evaluate new treatments for the disease.

Aaron Schimmer est une sommité internationale dans le domaine de la recherche sur les cancers sanguins, connus sous le nom de leucémies. Grâce à de nombreuses découvertes pionnières, il a démontré l’influence des voies mitochondriales et métaboliques sur le développement et la progression de la leucémie myéloïde aiguë. En tant que clinicien-scientifique, il a lancé des essais cliniques de phase précoce pour évaluer de nouveaux traitements de la maladie.